Ion Transport Dysregulation in Cilium-deficient ARPKD
Ion Transport Dysregulation in Cilium-deficient ARPKD
批准号:
7491635
负责人:
MARK Oliver BEVENSEE
金额:
$24.94万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2010-08-31
关键词:
AcidsAddressAffectAmilorideAnimalsApicalArchitectureAttenuatedAutosomal Recessive Polycystic KidneyBiochemical GeneticsBiological AssayBlood PressureBreedingBrush BorderCalciumCarrier ProteinsCell LineCell membraneCellsCellular MorphologyCiliaClone CellsCollaborationsComplementCritiquesCystic Kidney DiseasesCystic kidneyDataDefectDepthDiseaseDisease ProgressionDoctor of PhilosophyDuct (organ) structureElectrical ResistanceEpithelialEpithelial CellsExcretory functionFluorescenceGenerationsGeneticGenetic CrossesGoalsHandHumanHypertensionIn VitroIon TransportIonsKidneyKnockout MiceLaboratoriesLeadLifeLiteratureLocalizedLongevityMeasurementMeasuresMediatingMembraneMembrane ProteinsMolecularMorphologyMusMutationNatureNewborn AnimalsNickelOsmolalitiesPatientsPhenotypePhospholipidsPlasmaPlayPolycystic Kidney DiseasesProtease InhibitorProteinsReagentRenal tubule structureResearchResearch PersonnelRoleSignal TransductionSodiumSodium ChlorideStructureSurfaceTestingTherapeuticTrace ElementsTransgenic MiceTubular formationUp-RegulationUrineWeekWorkZincabsorptionanalogapical membraneautocrinebasebenzamilchelationcollecting tubule structuredaydesigndisease phenotypeearly onsetepithelial Na+ channelethylisopropylamilorideexperienceextracellularin vivoinhibitor/antagonistkidney cellmetabolic abnormality assessmentmonolayermouse modelmutantnovel therapeuticsprogramsresponseurinary
中文摘要
描述(由申请人提供):在人类或小鼠模型中,多囊肾病(PKD)的两种遗传形式都表现为肾小管或上皮细胞形态和结构的深刻变化,这是由于至少部分定位于皮质集管(CCD)主细胞(PC细胞)的顶端中央单毛的蛋白质突变。一旦PKD的遗传和生化后果表现在这种形态变化上,细胞或管状结构的变化就会深刻地影响上皮离子转运。在人类常染色体隐性PKD (ARPKD)单分子层中,有证据表明钠的过度吸收,尽管钠的运输机制尚未明确定义。这种异常可以解释在大多数人类ARPKD患者中观察到的早发性高血压。利用小鼠肾上皮细胞,由于与不朽小鼠的遗传杂交而永生,并从橡树岭多囊肾(orpk)小鼠CCD的野生型,突变型和遗传拯救的PC细胞形成极化上皮细胞单层,具有非常高的电阻,我们的实验室收集了初步数据,显示小鼠orpk ARPKD突变的皮质集管(CCD)主上皮细胞(PC细胞)生长为极化单层,缺乏顶端中央单纤毛,而与对照的纤毛敏感的PC细胞单层相比,吸收性钠转运上调。这些上调的钠电流可能代表ENaC和nhe介导的钠高吸收。综上所述,我们的文献,我们合作研究小组的经验,我们目前的初步工作,以及我们最初申请的评论者的建设性批评使我们制定了以下工作假设:缺乏根尖中央单纤毛的ARPKD小鼠模型的ccd上调了ENaC和nhe介导的钠吸收和由此产生的高血压。相关的特定目标源于这一假设,旨在了解这种ARPKD疾病表型背后的细胞和分子机制。
英文摘要
DESCRIPTION (provided by applicant): Both genetic forms of polycystic kidney disease (PKD) present in human or mouse models as a profound change in renal tubule or epithelial cell morphology and architecture due to mutations in proteins that localize, at least in part, to the apical central monocilium of the cortical collecting duct (CCD) principal cell (PC cell). Once the genetic and biochemical consequences of PKD are manifested in this change in morphology, the change in cellular or tubular architecture affects transepithelial ion transport profoundly. In human autosomal recessive PKD (ARPKD) monolayers, there is evidence of sodium hyperabsorption, although the sodium transport mechanisms are not yet clearly defined. This abnormality may explain early onset hypertension observed in the majority of human ARPKD patients. Using mouse renal epithelial cells that are immortalized due to genetic cross with the Immortomouse and form polarized epithelial cell monolayers from wild-type, mutant, and genetically rescued PC cells from the Oak Ridge polycystic kidney (orpk) mouse CCD of very high electrical resistance, our laboratory has gathered preliminary data showing upregulated absorptive sodium transport in mouse orpk ARPKD mutant cortical collecting duct (CCD) principal epithelial cells (PC cells) grown as polarized monolayers and lacking apical central monocilia versus control cilium-competent PC cell monolayers. These upregulated sodium currents may represent ENaC- and NHE-mediated sodium hyperabsorption. Taken together, the literature, the experience of our collaborative research group, our current preliminary work, and the constructive criticism of the reviewers of our original application led us to formulate the following working hypothesis: CCDs from mouse models of ARPKD that lack apical central monocilia have upregulated ENaC- and NHE-mediated sodium absorption and resultant hypertension. Interrelated specific aims derive from this hypothesis and are designed to understand the cellular and molecular mechanisms that underlie this ARPKD disease phenotype.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frequency-dependent Modulation of Synaptic Transmission and Plasticity by pH
-
批准号:9324374
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2016
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Ion Transport Dysregulation in Cilium-deficient ARPKD
-
批准号:7669139
-
项目类别:
-
资助金额:$24.94万
-
财政年份:2005
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Ion Transport Dysregulation in Cilium-deficient ARPKD
-
批准号:7279915
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2005
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Na/Bicarbonate Cotransporters in Brain
-
批准号:6747560
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2003
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Na/Bicarbonate Cotransporters in Brain
-
批准号:7906809
-
项目类别:
-
资助金额:$40.29万
-
财政年份:2003
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Na/Bicarbonate Cotransporters in Brain
-
批准号:6893285
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2003
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Na/Bicarbonate Cotransporters in Brain
-
批准号:7052894
-
项目类别:
-
资助金额:$26.9万
-
财政年份:2003
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Na/Bicarbonate Cotransporters in Brain
-
批准号:6677218
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2003
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
Na/Bicarbonate Cotransporters in Brain
-
批准号:7236047
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2003
-
负责人:MARK Oliver BEVENSEE
-
依托单位:
海外基金